Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Qilu Pharma Announces $1 Billion Biopharma Park in Jinan

publication date: Aug 16, 2013
Qilu Pharmaceutical will spend 6 billion RMB ($1 billion) to construct a biopharmaceutical park in its home town of Jinan, located in eastern China’s Shangdong Province. The 8 million square foot park will include an R&D facility, a manufacturing plant for cancer treatments and a monoclonal antibody drug facility. The company said it will seek to establish cooperative projects with global top 20 pharmas to take advantage of the expanded capacity provided by the park. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital